Event Details
The earnings call is scheduled to discuss the company's operational and financial performance for the quarter and half year ended on 30th September 2026.
Date & Time: Thursday, 29th October 2026 at 12:00 noon IST
Management Participants
The management team will be represented by:
- Mr. Sujit Bhayani – Managing Director
- Mr. Shanil Bhayani – Director
- Mr. Ketan Vyas – Chief Financial Officer
Additional Information
The earnings call invitation is annexed to the disclosure and is also hosted on the company's website at https://www.sudeeppharma.com/investor-relations/financial-results/#concall-invitation
For further information, participants can contact Mr. Rohit Nagraj of 360 ONE Capital Market Research at +91-22-4031 7127 or rohit.nagraj@360.one
Financial Impact
No financial results or performance figures are disclosed in this intimation. The call will discuss operational and financial performance for Q2 and H1 FY27.